<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067963</url>
  </required_header>
  <id_info>
    <org_study_id>08-0939</org_study_id>
    <secondary_id>1UL1RR025780</secondary_id>
    <secondary_id>RWJ64198</secondary_id>
    <nct_id>NCT01067963</nct_id>
  </id_info>
  <brief_title>Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease</brief_title>
  <acronym>SMaRT</acronym>
  <official_title>Self-management of Type 2 Diabetes and Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Robert Wood Johnson Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the usefulness and the impact of a tailored
      behavioral-education and counseling intervention titled Self-Management and Resourceful
      Transition (S.M.a.R.T) among patients with type 2 diabetes mellitus and stage 3 chronic
      kidney disease, in order to help them to manage their behaviors related to their condition
      and health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SMaRT intervention is a 3-week intervention that uses a combined behavioral-education and
      counseling methodology. The combined intervention involves computer-aided education alongside
      telephone counseling via motivational interviewing. The computer-aided education is tailored
      to the diagnoses of type 2 diabetes and chronic kidney disease and designed in a learning
      module approach to facilitate goal-setting and discussion of health concerns with greater
      efficacy and in a more informed way during the brief office visit. Such Computer-aided
      education has been used to improve diabetes self-management and glycemic control in
      middle-aged to older adults with moderate success. The inclusion of CKD information will
      augment current diabetes self-management intervention. The telephone counseling using the
      evidence-based behavioral change approach of motivational interviewing is a patient-centered
      approach of partnering with patients by eliciting their health-related concerns. This
      approach tailors the SMaRT intervention to include collaborative goal-setting with guidance
      based upon the patient's readiness for change.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcomes utilized in this study will be disease burden (measured as diabetes-related distress), quality of life (measured as health related QOL), and glycemic health (measured as hemoglobin A1C).</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary exploratory outcomes for quality of life include measures of health-related quality of life for diabetes and overall quality of life.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>Behavioral-education/counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Computer assisted education and telephone counseling using motivational interviewing.
Computer assisted education and motivational interviewing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group talks/social chat</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group session talks on general topics about healthy lifestyle, printed power point handouts, telephone calls comprised of social conversation to discuss the handout content.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Computer assisted education and motivational interviewing.</intervention_name>
    <description>9 study contact points. 3-week intervention using computer-assisted learning modules and telephone counseling using motivational interviewing.</description>
    <arm_group_label>Behavioral-education/counseling</arm_group_label>
    <other_name>Experimental Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group talks/social chat</intervention_name>
    <description>9 study contact points. 3 group talk session on general topics about healthy lifestyle, printed power point handouts, telephone calls comprised of social conversation to discuss the handout content.</description>
    <arm_group_label>Group talks/social chat</arm_group_label>
    <other_name>Attention Control Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed Type 2 Diabetes

          -  18-85 years old

          -  Stage 3 Chronic Kidney Disease

          -  Speaks and reads English

        Exclusion Criteria:

          -  Hypoglycemia with 3rd party treatment in past 3 months

          -  Type 1 Diabetes

          -  On Dialysis

          -  Does not speak English

          -  Factors likely to preclude protocol adherence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teresa J. Sakraida, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado Denver College of Nursing</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alkesh Jani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado Denver, School of Medicine and VA Eastern Colorado Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Eastern Colorado Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003 Jan;41(1):1-12.</citation>
    <PMID>12500213</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. Evidenced based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 26:S51-S61, 2003.</citation>
  </reference>
  <reference>
    <citation>Berridge E, Roudsari A, Taylor S, Carey S. Computer-aided learning for the education of patients and family practice professionals in the personal care of diabetes. Comput Methods Programs Biomed. 2000 Jul;62(3):191-204.</citation>
    <PMID>10837906</PMID>
  </reference>
  <reference>
    <citation>National Kidney Foundation [NKF]. Kidney disease outcomes quality initiative (K/DOQI): Clinical Practice Guideline 2-evaluation and treatment 2002: Accessed March 21, 2008 from http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g2.htm.</citation>
  </reference>
  <reference>
    <citation>Khosla N, Bakris G. Lessons learned from recent hypertension trials about kidney disease. Clin J Am Soc Nephrol. 2006 Mar;1(2):229-35. Epub 2005 Nov 30. Review.</citation>
    <PMID>17699211</PMID>
  </reference>
  <reference>
    <citation>Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. Am J Kidney Dis. 2000 Apr;35(4):695-707.</citation>
    <PMID>10739792</PMID>
  </reference>
  <reference>
    <citation>National Kidney Foundation [NKF]. Kidney Disease Outcomes Quality Initiative (K/DOQI): Clinical Practice Guideline 9-assoc of level of GFR with nutritional status and Guideline 24-dietary protein intake for nondialyzed patients, 2002.</citation>
  </reference>
  <reference>
    <citation>Perlman RL, Kiser M, Finkelstein F, Eisele G, Roys E, Liu L, Burrows-Hudson S, Port F, Messana JM, Bailie G, Rajagopalan S, Saran R. The longitudinal chronic kidney disease study: a prospective cohort study of predialysis renal failure. Semin Dial. 2003 Nov-Dec;16(6):418-23.</citation>
    <PMID>14629599</PMID>
  </reference>
  <reference>
    <citation>KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007 Feb;49(2 Suppl 2):S12-154.</citation>
    <PMID>17276798</PMID>
  </reference>
  <reference>
    <citation>Glasgow RE, Hiss RG, Anderson RM, Friedman NM, Hayward RA, Marrero DG, Taylor CB, Vinicor F. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care. 2001 Jan;24(1):124-30. Review.</citation>
    <PMID>11194217</PMID>
  </reference>
  <reference>
    <citation>Rollnick S, Mason P, Butler C. Health behavior change: A guide for practitioners. Edinburgh, Scotland: Churchill Livingstone Elsevier; 1999.</citation>
  </reference>
  <reference>
    <citation>Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. In: Hersen M, Eisler R, eds. Progress in behavior modification. Newbury Park, CA: Sage Publications; 1992.</citation>
  </reference>
  <reference>
    <citation>Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care: Helping patients change behavior. New York: Guilford Press; 2007.</citation>
  </reference>
  <reference>
    <citation>Glasgow RE, Boles SM, McKay HG, Feil EG, Barrera M Jr. The D-Net diabetes self-management program: long-term implementation, outcomes, and generalization results. Prev Med. 2003 Apr;36(4):410-9.</citation>
    <PMID>12649049</PMID>
  </reference>
  <reference>
    <citation>Gerber BS, Brodsky IG, Lawless KA, Smolin LI, Arozullah AM, Smith EV, Berbaum ML, Heckerling PS, Eiser AR. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Diabetes Care. 2005 Jul;28(7):1574-80.</citation>
    <PMID>15983303</PMID>
  </reference>
  <reference>
    <citation>Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91-111. Review.</citation>
    <PMID>17716083</PMID>
  </reference>
  <reference>
    <citation>Brown SA. Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revisited. Patient Educ Couns. 1990 Dec;16(3):189-215.</citation>
    <PMID>2149753</PMID>
  </reference>
  <reference>
    <citation>Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA. 2007 Jun 20;297(23):2630-3.</citation>
    <PMID>17579231</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012.</citation>
    <PMID>18165335</PMID>
  </reference>
  <reference>
    <citation>Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S; Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004 Sep;23(5):443-51.</citation>
    <PMID>15367063</PMID>
  </reference>
  <reference>
    <citation>Sakraida TJ, Robinson MV. Health literacy self-management by patients with type 2 diabetes and stage 3 chronic kidney disease. West J Nurs Res. 2009 Aug;31(5):627-47. doi: 10.1177/0193945909334096. Epub 2009 Apr 23.</citation>
    <PMID>19390053</PMID>
  </reference>
  <reference>
    <citation>Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE. Assessment of diabetes-related distress. Diabetes Care. 1995 Jun;18(6):754-60.</citation>
    <PMID>7555499</PMID>
  </reference>
  <reference>
    <citation>Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005 Mar;28(3):626-31.</citation>
    <PMID>15735199</PMID>
  </reference>
  <reference>
    <citation>Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994 Oct;3(5):329-38.</citation>
    <PMID>7841967</PMID>
  </reference>
  <reference>
    <citation>Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8(1-2):79-91.</citation>
    <PMID>10457741</PMID>
  </reference>
  <reference>
    <citation>Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Centre;1993.</citation>
  </reference>
  <reference>
    <citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.</citation>
    <PMID>1593914</PMID>
  </reference>
  <reference>
    <citation>Woodcock AJ, Julious SA, Kinmonth AL, Campbell MJ; Diabetes Care From Diagnosis Group. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res. 2001;10(8):661-70.</citation>
    <PMID>11871587</PMID>
  </reference>
  <reference>
    <citation>Standards of Medical Care in Diabetes 2008. Diabetes Care 31:S12-S54, 2008.</citation>
  </reference>
  <reference>
    <citation>Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001 Nov-Dec;4(6):256-62.</citation>
    <PMID>11769298</PMID>
  </reference>
  <reference>
    <citation>Kavookjian J, Berger B, Anderson-Harper H, Barker K, Grimley D, Pearson R, et al. The relationship between readiness for diabetes self-care and glycemic control: The development of a diagnostic tool for pharmacist intervention. Journal of American Pharmaceutical Association 41:320, 2001.</citation>
  </reference>
  <reference>
    <citation>Greene GW, Rossi SR, Rossi JS, Velicer WF, Fava JL, Prochaska JO. Dietary applications of the stages of change model. J Am Diet Assoc. 1999 Jun;99(6):673-8. Review.</citation>
    <PMID>10361528</PMID>
  </reference>
  <reference>
    <citation>Hellsten LA, Nigg C, Norman G, Burbank P, Braun L, Breger R, Coday M, Elliot D, Garber C, Greaney M, Lees F, Matthews C, Moe E, Resnick B, Riebe D, Rossi J, Toobert D, Wang T. Accumulation of behavioral validation evidence for physical activity stage of change. Health Psychol. 2008 Jan;27(1S):S43-53. doi: 10.1037/0278-6133.27.1(Suppl.).S43.</citation>
    <PMID>18248105</PMID>
  </reference>
  <reference>
    <citation>Greene GW, Rossi SR, Reed GR, Willey C, Prochaska JO. Stages of change for reducing dietary fat to 30% of energy or less. J Am Diet Assoc. 1994 Oct;94(10):1105-10; quiz 1111-2.</citation>
    <PMID>7930314</PMID>
  </reference>
  <reference>
    <citation>Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul;23(7):943-50.</citation>
    <PMID>10895844</PMID>
  </reference>
  <reference>
    <citation>Stanford Patient Education Research Center, Self Efficacy for Diabetes. Stanford (Accessed March 28, 2008, at http://patienteducation.stanford.edu/research/sediabetes.html.)</citation>
  </reference>
  <reference>
    <citation>National Kidney Foundation [NKF]. Kidney disease outcomes quality initiative (K/DOQI): Clinical practice Guideline 4-Estimation of GFR Part 5 evaluation of laboratory measures for clinical assessment of kidney disease. 2002: Accessed March 27, 2008 from http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p5_lab_g4.htm.</citation>
  </reference>
  <reference>
    <citation>Lynn ML. Determination and quantification of content validity. Nursing Research 35:362-5, 1996.</citation>
  </reference>
  <reference>
    <citation>Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther. 1995 Jan;57(1):6-15. Review.</citation>
    <PMID>7828382</PMID>
  </reference>
  <reference>
    <citation>Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan JP. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med. 1998 Oct 15;129(8):605-12.</citation>
    <PMID>9786807</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2010</study_first_submitted>
  <study_first_submitted_qc>February 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2010</study_first_posted>
  <last_update_submitted>June 5, 2015</last_update_submitted>
  <last_update_submitted_qc>June 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>self-care</keyword>
  <keyword>self-management</keyword>
  <keyword>health behavior change</keyword>
  <keyword>motivational interviewing</keyword>
  <keyword>computer assisted learning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

